Iradimed (IRMD) Gross Profit (2013 - 2026)

Iradimed (IRMD) has 14 years of Gross Profit data on file, last reported at $16.8 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 13.28% year-over-year to $16.8 million in Q1 2026; TTM through Mar 2026 was $66.3 million, a 14.69% increase from a year earlier, with the FY2025 full-year figure at $64.3 million, up 14.15% from the prior year.
• Gross Profit for Q1 2026 stood at $16.8 million, down from $17.0 million in the prior quarter.
• Over the last five years, Gross Profit for IRMD reached as high as $17.0 million in Q4 2025 and fell as low as $9.4 million in Q1 2022.
• Historically, Gross Profit has averaged $13.5 million across 5 years, with a median of $13.4 million in 2023.
• Across the five-year window, Gross Profit soared 38.29% in 2022 and climbed 10.05% in 2024, its largest moves.
• Year by year, Gross Profit stood at $11.2 million in 2022, then advanced by 19.54% to $13.4 million in 2023, then climbed by 10.05% to $14.8 million in 2024, then climbed by 15.38% to $17.0 million in 2025, then retreated by 1.28% to $16.8 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $16.8 million in Q1 2026, $17.0 million in Q4 2025, and $16.5 million in Q3 2025.